Placental Function Overview

Principles

Definition

Placental function is the academic field dedicated to the comprehensive investigation of the physiological processes and molecular mechanisms underlying the placenta's roles in sustaining pregnancy and supporting fetal development. This research area examines critical functions including nutrient and gas exchange, waste elimination, hormone production, immune modulation at the maternal-fetal interface, and the intricate regulation of fetal growth and well-being. As a multidisciplinary concept, it integrates insights from developmental biology, endocrinology, immunology, and cellular physiology to understand this dynamic organ, and is crucial for advancing knowledge of healthy gestation, identifying causes of pregnancy complications, and understanding developmental programming effects on long-term health.

Ontological type

Core Functions

Pathological Alterations

Regulatory Mechanisms

Key developments

Key Figures

Foundational Placental Physiology era

Abraham M. Rudolph[1] was active at Harvard University[3] and the University of California, San Francisco[4] during the Foundational Placental Physiology era (1952–1980). His key contribution, exemplified by The Circulation of the Fetus in Utero[7] (1967), advanced quantitative understanding of fetal hemodynamics and placental endocrine integration, shaping how researchers viewed placental regulation of fetal oxygenation and substrate delivery. Paul C. MacDonald[2] was affiliated with The University of Texas Southwestern Medical Center[5] and The University of Texas Health Science Center at San Antonio[6] during this era. His notable contribution, as reflected in Placental Estrogen Biosynthesis During Human Pregnancy[8] (1966), clarified placental steroidogenesis and estrogen production, establishing a mechanistic basis for placental endocrine output in fetal development.

Oxygen-Angiogenic Signaling era

S. Ananth Karumanchi [1] is a physician-scientist active in the Oxygen-Angiogenic Signaling era, affiliated with Harvard University [3] and Baylor College of Medicine [4]. His key contributions include the characterization of excess placental soluble fms-like tyrosine kinase 1 (sFlt1) as a mediator of endothelial dysfunction, hypertension, and proteinuria in preeclampsia, as described in the 2003 paper Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [6], a finding that linked placental oxygen signaling to maternal vascular pathology. Susan J. Fisher [2] is a prominent figure at Harvard University [3] and the University of California, San Francisco [5] during this era. Her key contributions include the Regulation of Human Placental Development by Oxygen Tension [7] (1997), Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface [8] (2004), and Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia [9] (1996), collectively advancing our understanding of how oxygen availability shapes trophoblast behavior, invasion, and placental vascular remodeling.

Molecular Programming and Organoids era

Graham J. Burton [1] is a leading placental researcher affiliated with Washington University in St. Louis [3] and the University of Cambridge [4] during this era. His contributions include establishing trophoblast organoids as a model for maternal–fetal interactions [7], detailing Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice [8], and highlighting Placental-Specific Igf2 Deficiency Alters Developmental Adaptations to Undernutrition in Mice [9], which collectively advanced mechanistic understanding of nutrient transport and fetal growth regulation. Shigeki Matsubara [2] is a researcher associated with Harbin Medical University [5] and the University of Colorado Denver [6] in this era. His 2009 paper Human Villous Trophoblasts Express and Secrete Placenta-Specific MicroRNAs into Maternal Circulation via Exosomes1 [10] demonstrated placenta-derived microRNAs being packaged into exosomes and released into maternal circulation, highlighting their potential as diagnostic biomarkers and regulators of maternal–fetal signaling in this era.